Drug Market To Grow At A 9.1% CAGR Over 10 Years

The Peruvian pharmaceutical market is the smallest in BMI's coverage of the Latin American region. Nevertheless, Peru offers considerable longer-term benefits to foreign companies, not least because its population is expected to top 30mn by the end of 2010. The recently-ratified free trade agreement (FTA) with the US is viewed as a positive development, with Peruvian businesses gaining access to the largest market in the world and US companies benefiting from improved regulatory conditions. In the meantime, the country's economic development is forecast to experience a modest but steady growth, with real GDP growth and fiscal expenditure forecast to increase,

To read the full article, please choose one of the following options: